Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
Launched by CHILDREN'S HOSPITAL OF PHILADELPHIA · Jul 8, 2015
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving the safety and quality of procedures used to help children breathe in critical situations, such as when they need to be intubated (a tube placed in the windpipe to assist with breathing). These advanced airway procedures are often performed in pediatric intensive care units (ICUs) and emergency departments (EDs) and can be quite risky. The goal of the study is to find better ways to carry out these procedures, especially in cases where they are difficult or have failed in the past.
Children of all ages who have experienced specific breathing emergencies, like needing intubation or other airway interventions, may be eligible to participate. The trial is currently recruiting participants and welcomes children regardless of gender. If your child is involved, you can expect to be part of a study that aims to make these life-saving procedures safer for kids in the future. It's important to note that this study will not include children who have had these airway procedures done in operating rooms.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Primary advanced airway events (on patients of all ages) in the PICU, CICU, NICU, DR and ED including: Tracheal Intubation, Laryngeal mask placement, Emergency tracheostomy and/or cricothyrotomy
- • Failed extubation attempts or unplanned extubations that require re-intubation will be considered a new primary intubation.
- Exclusion Criteria:
- • Primary advanced airway events (tracheal intubations, laryngeal mask placement, emergency tracheostomy and/or cricothyrotomy) in the Operating Suites.
About Children's Hospital Of Philadelphia
The Children's Hospital of Philadelphia (CHOP) is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and clinical care. As a prominent clinical trial sponsor, CHOP emphasizes a multidisciplinary approach to pediatric research, fostering collaborations across various specialties to develop and evaluate groundbreaking therapies and interventions. With a focus on improving patient outcomes and enhancing the quality of life for children, CHOP is dedicated to conducting rigorous clinical trials that adhere to the highest ethical standards and scientific integrity, ultimately contributing to the global knowledge base in pediatric medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Milwaukee, Wisconsin, United States
Springfield, Massachusetts, United States
Vancouver, British Columbia, Canada
Miami, Florida, United States
Phoenix, Arizona, United States
Atlanta, Georgia, United States
Aurora, Colorado, United States
Seattle, Washington, United States
Portland, Oregon, United States
Columbus, Ohio, United States
Seattle, Washington, United States
Indianapolis, Indiana, United States
Morristown, New Jersey, United States
Lebanon, New Hampshire, United States
Albany, New York, United States
Calgary, Alberta, Canada
Little Rock, Arkansas, United States
Philadelphia, Pennsylvania, United States
Boston, Massachusetts, United States
Providence, Rhode Island, United States
Pittsburgh, Pennsylvania, United States
Hiroshima, , Japan
Auckland, , New Zealand
Akron, Ohio, United States
Raleigh, North Carolina, United States
New Haven, Connecticut, United States
Madera, California, United States
Omaha, Nebraska, United States
New Hyde Park, New York, United States
Bronx, New York, United States
Dallas, Texas, United States
New Haven, Connecticut, United States
Setagaya Ku, Tokyo, Japan
Memphis, Tennessee, United States
Baltimore, Maryland, United States
Raleigh, North Carolina, United States
Montreal, Quebec, Canada
Charlottesville, Virginia, United States
Richmond, Virginia, United States
New York, New York, United States
Singapore, , Singapore
Hershey, Pennsylvania, United States
Atlanta, Georgia, United States
Augusta, Georgia, United States
South Bend, Indiana, United States
Lexington, Kentucky, United States
Louisville, Kentucky, United States
Baltimore, Maryland, United States
Saint Paul, Minnesota, United States
Saint Paul, Minnesota, United States
Buffalo, New York, United States
Rochester, New York, United States
Stony Brook, New York, United States
Valhalla, New York, United States
Durham, North Carolina, United States
Cincinnati, Ohio, United States
Hershey, Pennsylvania, United States
Burlington, Vermont, United States
Madison, Wisconsin, United States
Calgary, Alberta, Canada
Montréal, Quebec, Canada
Luebeck, , Germany
Bangalore, , India
Roma, , Italy
Kobe, , Japan
Obu, , Japan
Saitama, , Japan
Shimotsuke, , Japan
Tokyo, , Japan
Singapore, , Singapore
Herston, , Australia
Parkville, , Australia
Birmingham, Alabama, United States
Chicago, Illinois, United States
Wilmington, Delaware, United States
Cleveland, Ohio, United States
Austin, Texas, United States
Vienna, , Austria
Winnipeg, , Canada
Bengaluru, Karnataka, India
Cardiff, Wales, United Kingdom
Irving, Texas, United States
San Antonio, Texas, United States
San Antonio, Texas, United States
Madison, Wisconsin, United States
Shorewood Hills, Wisconsin, United States
Patients applied
Trial Officials
Vinay Nadkarni, MD. MS
Principal Investigator
Children's Hospital of Philadelphia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials